Clinical Trials Browser

Phase 3 × Interventional × afuresertib × Clear all

NCT04851613 2025-09-16

Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Phase 3 Recruiting

Breast Neoplasms